Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|May 8, 2013
Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13Jean-Baptiste Bachet, Bruno Landi, Pierre Laurent-Puig, et al.Clinics and Research in Hepatology and Gastroenterology|November 13, 2012
Chemosensitivity in ovarian metastases from gastric cancer: a case seriesBertrand Brieau, Hélène Roussel, Theofano Markoutsaki, et al.Gastrointestinal Endoscopy|September 28, 2005
The European experience with double-balloon enteroscopy: indications, methodology, safety, and clinical impactSimona Di Caro, Andrea May, Dimitri G N Heine, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapyThierry Lecomte, Jean-Marc Ferraz, Franck Zinzindohoué, et al.Clinics and Research in Hepatology and Gastroenterology|November 20, 2012
Double pancreatic and gastric adenocarcinomas: a rare associationHampig Raphael Kourie, Nina Markoutsaki, Hélène Roussel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2023
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyChristophe Tournigand, Thierry André, Emmanuel Achille, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2003
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR studyChristophe Tournigand, Thierry André, Emmanuel Achille, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 8, 2019
Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)Bruno Landi, Jean-Yves Blay, Sylvie Bonvalot, et al.Cancer Research|April 19, 2006
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancerAstrid Lièvre, Jean-Baptiste Bachet, Delphine Le Corre, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 7, 2013
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohortSimon Pernot, Emmanuel Mitry, Emmanuelle Samalin, et al.Pageof 6